Trex Medical acquires XRE for $17 million:
This article was originally published in Clinica
ThermoTrex subsidiary Trex Medical has purchased XRE, a manufacturer of specialised X-ray systems for the diagnosis of coronary artery disease, for around $17 million. ThermoTrex produces mammography and stereotactic needle-biopsy systems and general X-ray equipment. Littleton, Massachusetts-based XRE had a turnover of $29.3 million in 1995. Trex Medical estimates the market for imaging systems used in cardiac catheterisation at $1 billion.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.